Scleric acid |
(2‐(benzoyloxy) acetyl)‐L‐proline |
Mycobacterium tuberculosis
|
Streptomyces sclerotialus NRRL ISP‐5269 |
Heterologous expression in Streptomyces albus J1074 |
(Alberti et al., 2019) |
Enterocin |
Polyketide |
Cytotoxic |
Salinispora pacifica CNT‐150 |
Heterologous expression in Streptomyces coelicolor M1146 |
(Bonet et al., 2014) |
Borregomycin A |
Indolotryptoline |
CaMKIIδ kinase inhibition |
Metagenomic DNA from Anza‐Borrego Desert soil |
Heterologous expression in Streptomyces albus J1074 |
(Chang and Brady, 2013) |
Avermectins |
Polyketides |
Antihelminthic |
Streptomyces avermitilis ATCC 31267 |
Heterologous expression in Streptomyces lividans 1326 |
(Deng et al., 2017) |
Tetarimycin A |
Polyketide |
MRSA |
Metagenomic DNA |
Heterologous expression in Streptomyces albus J1074 |
(Kallifidas et al., 2012) |
Cosmomycins |
Polyketides |
Cytotoxic |
Streptomyces sp. CNT‐302 |
Heterologous expression in Streptomyces coelicolor M512 |
(Larson et al., 2017) |
Alterochromide |
Lipopeptide |
Antibacterial, cytotoxic |
Pseudoalteromonas piscicida JCM 20779 |
Heterologous expression in Escherichia coli BL21(DE3) |
(Ross et al., 2015) |
Taromycin A |
NP peptide |
Antibacterial |
Saccharomonospora sp. CNQ490 |
Heterologous expression in Streptomyces coelicolor M512 |
(Yamanaka et al., 2014) |
Streptoseomycin |
Polyketide |
Helicobacter pylori
|
Streptomyces seoulensis A01 |
Heterologous expression in Streptomyces chartreusis 1018 |
(Zhang et al., 2018) |
Actinoallolides |
Polyketides |
Anti‐trypanosomal |
Actinoallomurus fulvus MK10‐037 |
Heterologous expression in Streptomyces coelicolor M1152 |
(Inahashi et al., 2018) |
Thaxtomins |
Nitrated diketopiperazines |
Herbicide |
Streptomyces scabiei 87.22 |
Heterologous expression in Streptomyces albus J1074 |
(Jiang et al., 2018) |
Syringolin |
NR peptide |
Cytotoxic |
Pseudomonas syringae pv. syringae (Pss) B728a |
Heterologous expression in Streptomyces lividans TK24 |
(Huang et al., 2018) |
Pseudomycoicidin |
Lantibiotic |
Antibacterial |
Bacillus pseudomycoides DSM 12442 |
Heterologous expression in Escherichia coli BL21(DE3) |
(Basi‐Chipalu et al., 2015) |
Amicoumacin |
Dihydroisocoumarin |
Antibacterial |
Bacillus subtilis 1779 |
Heterologous expression in Bacillus subtilis JH642 |
(Li et al., 2015) |
Pyxidicyclines |
Polyketides |
Topoisomerase inhibitor |
Pyxidicoccus fallax An d48 |
BGC activation and heterologous expression |
(Panter et al., 2018) |
Chattamycins |
Polyketides |
Cytotoxic |
Streptomyces chattanoogensis L10 |
Overexpression of pathway‐specific activator |
(Zhou et al., 2015) |
Stambomycins |
Polyketides |
Cytotoxic |
Streptomyces ambofaciens ATCC 23877 |
Overexpression of pathway‐specific activator |
(Laureti et al., 2011) |
Coelimycin P1 |
Polyketide |
Antibacterial |
Streptomyces coelicolor A3(2) |
Inactivation of pathway‐specific repressor |
Gomez‐Escribano et al., 2012; |
Gacamide A |
Lipopeptide |
Antibacterial |
Pseudomonas fluorescens Pf0‐1 |
Repair of defective pathway‐specific activator |
Jahanshah et al., 2019; |
Atolypenes |
Sesterterpenes |
Cytotoxic |
Amycolatopsis tolypomycina NRRL B‐24205 |
Cas9‐TAR BGC refactoring |
Kim et al., 2018
|